Rescue Lung, Rescue Life, 18 Feb 2016 To view the full text, please login as a subscribed user or purchase a subscription. Click here to view the full text on…
日本がん対策新聞, 06 Feb 2016 【肺がん】抗PD-L1抗体「durvalumab」 +抗CTLA-4抗体「 tremelimumab」の第Ⅰb相試験の結果発表。奏効率23%。〔Lancet Oncol〕 https://t.co/lkfGCxWvd8